» Articles » PMID: 35978346

Dexamethasone Suppresses the Proliferation and Migration of VSMCs by FAK in High Glucose Conditions

Overview
Publisher Biomed Central
Specialty Pharmacology
Date 2022 Aug 17
PMID 35978346
Authors
Affiliations
Soon will be listed here.
Abstract

Background: High glucose conditions cause some changes in the vessels of diabetes through the signal transduction pathways. Dexamethasone and other corticosteroids have a wide range of biological effects in immunological events. In the present study, the effects of dexamethasone were investigated on the VSMC (vascular smooth muscle cell) proliferation, and migration based on the FAK gene and protein changes in high glucose conditions.

Methods And Materials: The vascular smooth muscle cells were cultured in DMEM and were treated with dexamethasone (10 M, 10 M, and 10 M) for 24, and 48 h in high glucose conditions. The cell viability was estimated by MTT method. The FAK gene expression levels and pFAK protein values were determined by RT-qPCR and western blotting techniques, respectively. A scratch assay was used to evaluate cellular migration.

Results: The FAK gene expression levels decreased significantly dependent on dexamethasone doses at 24 and 48 h. The pFAK protein values decreased significantly with a time lag at 24- and 48-h periods as compared with gene expression levels.

Conclusion: The results showed that the inhibition of VSMC proliferation and migration by dexamethasone in the high glucose conditions may be related to the changes of FAK.

Citing Articles

NF-kB affects migration of vascular smooth muscle cells after treatment with heparin and ibrutinib.

Shokri N, Ghasempour G, Soleimani A, Elahimanesh M, Najafi M Biochem Biophys Rep. 2024; 38:101685.

PMID: 38524279 PMC: 10957380. DOI: 10.1016/j.bbrep.2024.101685.


Glucocorticoid-induced thrombotic microangiopathy in paroxysmal nocturnal hemoglobinuria: A case report and review of literature.

Yang X, Ju B, Xu J, Xiu N, Sun X, Zhao X World J Clin Cases. 2023; 11(8):1799-1807.

PMID: 36970013 PMC: 10037281. DOI: 10.12998/wjcc.v11.i8.1799.

References
1.
Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C . Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330. PMC: 7308544. DOI: 10.1093/eurheartj/ehz962. View

2.
Chistiakov D, Orekhov A, Bobryshev Y . Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015; 214(1):33-50. DOI: 10.1111/apha.12466. View

3.
Li H, Telemaque S, Miller R, Marsh J . High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes. 2005; 54(2):540-5. DOI: 10.2337/diabetes.54.2.540. View

4.
Chawan-Saad J, Wu M, Wu A, Wu L . Corticosteroids for Diabetic Macular Edema. Taiwan J Ophthalmol. 2020; 9(4):233-242. PMC: 6947754. DOI: 10.4103/tjo.tjo_68_19. View

5.
Jeong K, Kim J, Murphy J, Park H, Kim S, Rodriguez Y . Nuclear Focal Adhesion Kinase Controls Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Through GATA4-Mediated Cyclin D1 Transcription. Circ Res. 2019; 125(2):152-166. PMC: 6702425. DOI: 10.1161/CIRCRESAHA.118.314344. View